Home /Pharmaceuticals Market Research Reports
Sort By: Title Date Price
15 Mar
2016

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market By Drug Type (Eluxadoline, Alosetron, Rifaximin, Loperamide, Diphenoxylate + Atropine, Dicyclomine and Hyoscyamine, Pipeline Drug Analysis: Ibodutant, Ramosetron), Prescription (Prescribed and OTC Drugs, Prescribed Branded and Prescribed Generic Drugs) - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022

The prevalence of Irritable Bowel Syndrome is growing at a phenomenal rate worldwide. Annually, millions of individuals are believed to suffer from the disorder; however, very few patients undergo appropriate diagnosis of the same. This drawback is majorly attributed to the unknown pathophysiology and robust risk factors for the condition. Subject to the dominant symptoms, IBS is categorized into three types:

$4325 Read More
15 Mar
2016

Opioid Induced Constipation (OIC) Drugs Market By Drug Type (Methylnaltrexone Bromide, Lubiprostone, Naloxegol, Naldemedine, Elobixibat, Alvimopan, Dolcanatide), By Prescription Type ( Prescribed Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Global Opioid Induced Constipation (OIC) market is estimated to hit USD 2,779.24 Mn in 2022 with a CAGR of 4.6% during 2016-2022. Europe contributes highest in global OIC market in 2014 followed by North America. North America is expected to contribute significantly in OIC market and expected to hit USD 1,167.3 Mn in 2022 with highest CAGR 5.6% during 2016-2022. Germany is expected to contribute highest in European market and expected to hit USD 306.7 Mn in 2014.

$4325 Read More
15 Mar
2016

Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type (Lubiprostone, Linaclotide, Pipeline Drug Analysis: Phase 3: Plecanatide, Elobixibat, Others), Prescription Type (Prescribed, Over the Counter Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

The global chronic idiopathic constipation (CIC) drugs market is moderately competitive and is characterized by a large demand for over the counter medications. Considering CIC as a symptom and not a disorder, there is a greater tendency of patients towards opting for self-medication through OTC drugs. This report on CIC drugs market studies, estimates and forecasts the market for various drugs indicated for the treatment of chronic idiopathic constipation. The global CIC drugs market report studies this market for drug types, prescription type and geographical distribution.

$4325 Read More
17 Mar
2016

Global Laxatives Market By Drugs (Senna, Bisacodyl, Docusate, Polyethylene Glycol 3350, Psyllium, Methylcellulose, Pipeline Drug Analysis: BLI 801, Others), Prescription (Prescribed, Over the Counter Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on global laxatives market studies various drugs used for treatment and management of constipation. The National Institute of Diabetes and Digestive and Kidney Diseases, U.S. defines constipation as 'condition in which you have fewer than three bowel movements a week, or hard, dry and small bowel movements that are painful or difficult to pass'.

$4325 Read More
20 Mar
2016

Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type (Lubiprostone, Linaclotide, Stimulant Laxatives, Osmotic Laxatives,) and By Prescription Type (Prescribed, Over the Counter Drugs) - Growth, Future Prospects, and Competitive Analysis, 2018 -2026

Irritable bowel syndrome (IBS) is defined as persistent abdominal discomfort and pain occurring with changed bowel habits. This condition is classified into three types centered upon the prevalent bowel habits; IBS with diarrhea (IBS-D), IBS with constipation (IBS-C) and IBS with mixed presentations (IBS-M). It is among the most common gastrointestinal disorders with a worldwide prevalence of approximately 11%. As of 2014, more than 30 million individuals older than age 19 suffered from IBS across key national markets namely the U.S., U.K. France, Italy, Germany, Japan and Spain.

$4325 Read More
14 Apr
2016

Angina Pectoris Treatment Market By Drug Type (Antiplatelet agents, Beta-adrenergic blocking agents, Calcium channel blockers, Short & Long – acting Nitroglycerines, Angiotensin-converting enzyme inhibitors, Anti-ischemic agents) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

This report on global angina pectoris treatment market studies various drugs used for treatment of angina pectoris along with pipeline analysis of upcoming potential drugs. Angina is chest pain due to transient myocardial ischaemia, which usually occurs with physical activity or emotional stress, in the United States 10.2 million are estimated to experience angina with approximately 500,000 new cases occurring each year. Thus, drug pipeline of angina pectoris treatment market comprises potential drugs which are specific and fast in therapeutic action.

$4325 Read More
02 May
2016

In-Vitro Diagnostics (IVD) Market By Products (Reagents, Instruments, Software And Services), By Techniques (Clinical Chemistry, Immunochemistry/Immunoassays, Hematology, Coagulation And Hemostasis, Microbiology, Molecular Diagnostics (MDX)), By Test Locations (Point-Of-Care Testing, Central Lab Testing, OTC/Self Testing) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

The global in-vitro diagnostics (IVD) market has considerably evolved over the past decade with the introduction of innovative diagnosis options. Major factors contributing to the growth of in-vitro diagnostics market include growing incidence of chronic diseases, aging population and growing demand for point-of-care testing. Advancements in the field of genomics and proteomics, introduction of condition-specific markers and development of healthcare infrastructure in emerging economies create future prospects for the market.

$4325 Read More
03 May
2016

Alzheimer’s Therapeutic Market By Drug Type (Memantine Hydrochloride, Donepezil Hydrochloride, Rivastigmine, Galantamine Hydrobromide) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

This report on global Alzheimer’s therapeutics market studies various drugs used for treatment of Alzheimer’s along with pipeline analysis of upcoming potential drugs. According to Institute of Health Metrics and Evaluation, Alzheimer’s is one of the most common diseases that cause dementia, which leads to a loss of cognitive abilities, including reasoning, thinking, and remembering. Alzheimer’s is an irreversible, progressive brain disease that eventually destroys the ability to carry out the most basic tasks of daily living.

$4325 Read More
05 May
2016

Osteoarthritis Treatment Market By Type (Analgesics, Non-Steroidal Anti-Inflammatory Drugs (Nsaids), Corticosteroids, Hyaluronic Acid, Pipeline Analysis) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

This report on global osteoarthritis treatment market studies various type of therapeutics used for treatment of osteoarthritis along with pipeline analysis of upcoming potential drugs. Globally, osteoarthritis is the eighth leading cause of disability with the joint most frequently associated with disability being the knee. The current treatment available for osteoarthritis treatment is incapable due to lack of efficacy and serious side-effects associated with the long term use.

$4325 Read More
17 May
2016

Listeria Monocytogenes Infections Treatment Market By Type Of Infection (Bacteremia, Meningitis, Brain Abscess, Gastroenteritis, Endocarditis, Pipeline Analysis) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on global Listeria monocytogenes infections treatment market studies various drugs used for treatment of Listeria monocytogenes infection’s along with pipeline analysis of upcoming potential drugs. According to Centers for Disease Control and Prevention (CDC), Listeriosis, a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes, is an important public health problem in the United States.

$4325 Read More
18 May
2016

ADME (Absorption, Distribution, Metabolism And Elimination) Toxicology Testing Market By Product ( Instruments, Software Solutions, Assay Systems, Reagents & Others), Technology (In-vitro Tests, In-vivo Tests) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on ADME toxicology testing market studies various product and technology types. ADME is the abbreviation for absorption, distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug.

$4325 Read More
19 May
2016

Autoimmune Diseases Treatment Market By Type (Chemical-based Drugs, Biological Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on global autoimmune diseases treatment market studies various drugs used for treatment of autoimmune diseases along with pipeline analysis of upcoming potential drugs. Autoimmune diseases (ADs) are a family of more than 80 chronic, and often disabling, illnesses broadly characterized by immune system dysfunction leading to the loss of tolerance to self-antigens, presence of increased level of autoantibodies, inflammatory and mediatory cells and resulting chronic inflammation.

$4325 Read More
26 May
2016

Intravenous Solutions Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Intravenous solutions present a combination of nutrients that support patients to get essential nutrition. The demand for intravenous solutions on the global front is undergoing steady growth and its market presents a higher growth in Asia-Pacific region. Intravenous products are highly regulated for quality and availability assurance.

$4325 Read More
31 May
2016

Von Willebrand Disease (VWD) Treatment: Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2020

According to World Federation of Hemophilia (WFH), von Willebrand disease (VWD) is the most common type of bleeding disorder. People with VWD have a problem with a protein in their blood called von Willebrand factor (VWF) that helps control bleeding. When a blood vessel is injured and bleeding occurs, VWF helps cells in the blood, called platelets, mesh together and form a clot to stop the bleeding. According to market experts, around 1% of the world’s population suffers from VWD, but due to presence of very mild symptoms only a few number of patients are aware about the condition.

$4325 Read More
01 Jun
2016

Cytomegalovirus (CMV) Infection Treatment Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2020

According to Centers for Disease Control and Prevention (CDC), Cytomegalovirus (CMV) is a common virus that infects people of all ages. Most CMV infections are opportunistic infections and can be observed in people with a weakened immune system and in babies infected before birth. Market experts suggest that, it is a common herpesvirus infection with a broad range of symptoms: from no symptoms to fever and fatigue to severe symptoms involving the eyes, brain, or other internal organs.

$4325 Read More
19 Jan
2017

Acquired Hemophilia Treatment Market By Type Of Therapeutics (Traditional Therapy, Advanced Therapy) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

According to National Organization of Rare Disorders (NORD), acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. In acquired hemophilia, the body produces antibodies that attack clotting factors, most often factor VIII. Medical practitioners suggest that, acquired hemophilia can potentially cause life-threatening bleeding complications in severe cases and in around 50% of cases, there is an identifiable underlying clinical condition; in the other 50% no cause is known i.e. idiopathic

$4325 Read More
09 Jun
2016

Tamoxifen Market - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Breast cancer is the most common form of cancer found in women across the globe. Although the rate of incidence of breast cancer has decreased in the past few years, reducing the mortality rate even further remains a big concern. Tamoxifen reduces the effects of the estrogen hormone in human body. The drug is used to treat/prevent breast cancer for both women and men. Tamoxifen can also be used to cure other kinds of cancers.

$4325 Read More
09 Jun
2016

Glioblastoma Multiforme Market By Drug Type (Bevacizumab, Temozolomide, Carmustine) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on global glioblastoma multiforme market studies various drugs used for treatment of glioblastoma along with pipeline analysis of upcoming potential drugs. Glioblastoma multiforme is the most common and most aggressive cancer that begins within the brain. According to Brain Tumour Foundation of Canada, The incidence of glioblastoma multiforme (GBM) is 2 to 3 per 100,000 people in the United States and Europe. GBM accounts for 12 to 15% of all intracranial tumours and 50 to 60 per cent of astrocytic tumours.

$4325 Read More
10 Jun
2016

Eosinophilic Pneumonia Treatment Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2020

Eosinophilic pneumonia is a pulmonary disease in which eosinophils accumulate in the lung and leads to disruption of the normal air spaces (alveoli) where oxygen is extracted from the atmosphere. Several different kinds of eosinophilic pneumonia exist and can occur in any age group. There are two types of eosinophilic pneumonia acute eosinophilic pneumonia (AEP) and chronic eosinophilic pneumonia (CEP).

$4325 Read More
16 Jun
2016

Contraceptives Market By Drug Type (Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Devices (Male Condoms, Female Condoms, Diaphragms, Contraceptive Sponges, Vaginal Rings, Subdermnal Implants, Intrauterine Devices) - Growth, Share, Opportunities, Competitive Analysis and Forecast 2016 - 2022

The contraceptives market is anticipated to undergo steady growth sue to increasing public awareness about reproductive health, prime driving factors of the global contraceptives market are technical advancement, preference for avoiding unintentional pregnancy and availability of highly effective female contraceptives.

$4325 Read More
16 Jun
2016

Breast Cancer Treatment Market By Drug Type (HER2 Inhibitors, Mitotic Inhibitors, Anti-metabolites, Aromatase Inhibitors, Hormone Receptor Antagonists) - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2022

This report on global breast cancer treatment market studies various drugs used for treatment of breast cancer along with pipeline analysis of upcoming potential drugs. Breast cancer is the second most common cancer observed in women worldwide, accounting for around 17% of all female cancers, making the disease exceptionally prevalent. The predictions shared by GLOBOCON in 2012 suggests that the incidence rate of breast cancer in 2012 was for ages<65 was 1.16 Mn and ages >= 65 was 503, 158 and by 2020 it is anticipated that ages<65 will be 1.33 Mn and ages >=65 will be 643,442.

$4325 Read More
17 Jun
2016

Microbiome Therapeutics Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Microbiome therapeutics market is an emerging market with abundant opportunities in today’s world. During the forecast period 2016 – 2022 market experts suggest that number of products currently involved in clinical trials proves the amount of research and development activities carried out across the world focusing on microbiome therapeutics. Considering the structure of the microbiome market the potential is quite large.

$4325 Read More
17 Jun
2016

Alopecia Treatment Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Alopecia, or excessive hair loss (baldness) is common in many men and some women in midlife. This condition may have significant psychological and emotional repercussions. The most effective treatment for alopecia depends on the inherent cause of the condition. The various causes of occurrence of alopecia in men and women are hormonal changes, heredity, stress, pollution, side effects of any medical treatment, dietary habits and chemicals.

$4325 Read More
20 Jun
2016

Parenteral Nutrition Market By Type (Carbohydrates, Amino Acids, Lipids, Electrolytes) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Parenteral nutrition or total parenteral nutrition is defined as intravenous infusion of nutrition solutions to patients. Parenteral nutrition is administered in cases where the GI tract is leaking or not functioning, is inaccessible or adequate nourishment from by enteral or oral means is not accomplished. The commercially available premixed solutions adequately provide nutrition for short periods, however for complex patients, it is ideal to adopt a flexible system for personalizing parenteral nutrition.

$4325 Read More
07 Jul
2016

Saline Laxatives Market By Drug Type (Magnesium Citrate, Magnesium Hydroxide, Sodium Phosphates), By Prescription Type (Prescribed and OTC Drugs) - Growth, Future Prospects and Competitive Assessment, 2016 - 2022

The National Institute of Diabetes and Digestive and Kidney Diseases, U.S. defines constipation as "condition in which you have fewer than three bowel movements a week, or hard, dry and small bowel movements that are painful or difficult to pass‟. Constipation is classified into two categories: functional constipation and secondary constipation. Functional constipation if further categorized into normal transit, slow transit and outlet constipation; secondary constipation is caused due to external medical conditions or intake of certain medications.

$4325 Read More
08 Jul
2016

Medical Gases Market By End Use (Hospitals and Clinics, Home Healthcare, Research and Academia, Pharmaceuticals and Biotechnology Industry) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

The medical gases industry is currently undergoing shift in standards and delivery due to modernization of institutional healthcare and home healthcare market and the means of supply to these areas. The medical gas sector is anticipated to undergo certain revisions in testing and supply requirements from the developed markets.

$4325 Read More
14 Jul
2016

Human Chorionic Gonadotropin Market By Treatment (Female Infertility Treatment, Oligospermia Treatment, Cryptorchidism Treatment), By Technology (Natural Source Extraction, Recombinant Dna Technology) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Fertility patterns worldwide have changed dramatically and a rise in the infertility rates have been observed since the last two decades. Even though newer assisted techniques such as in-vitro fertilization have been well developed, still fertility drugs are the first choice for treatment of infertility issues. Even in the fertility drugs category, hormonal products are preferred the most. Since the human body is governed by hormones, infertility is considered to be caused due to the abnormal play of the hormones.

$4325 Read More
21 Jul
2016

Hyaluronic Acid Products Market By Product Type (Single Injection, Three-Cycle Injection and Five-Cycle Injection), By Application (Vesicoureteral Reflux, Dermal Fillers, Ophthalmic and Osteoarthritis) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on hyaluronic acid products market studies various product types and applications. Hyaluronic acid products adds value to cell permeability and cell proliferation and considered as an vital constituent of the extracellular matrix. Hyaluronic acid products has extensive number of applications such as orthopedic surgery, rheumatology, ophthalmology, otolaryngology, dermatology and plastic surgery, wound healing and drug delivery.

$4325 Read More
26 Jul
2016

Angioedema Treatment Market By Treatments (Antihistamines, Cortecosteroids, Autoimmune Drugs, Antifibrinolytic Agents, Blood Protein Controllers), By Pipeline (Phase I, Phase II, Phase III) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.

$4325 Read More
28 Jul
2016

Precision Medicine Market By Applications (Oncology, Cardiovascular Diseases, Central Nervous System, Infectious Diseases) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

This report titled precision medicine market studies various technology type, application type and geographical scenario. In July 2016, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and built a genetic database of initially at least 1 million Americans. Market experts suggest that the proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.

$4325 Read More
09 Aug
2016

Ophthalmic Drugs Market By Prescription Type (Prescription Ophthalmic Drugs, OTC), By Therapeutics (Glaucoma, Retinal Disorder, Dry Eye, Allergic Conjunctivitis) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

Geriatric population is growing with the rising global population, and rising patient base suffering from ocular and eye related disorders has been a major growth driver that have urged the advent of ophthalmic drugs market. In the next few years the demand for ophthalmic drugs is expected to increase significantly in the emerging economies such as China and India.

$4325 Read More
11 Aug
2016

Bioactive Wound Care Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2023

Conventional wound healing turns out unproductive in healing acute wounds such as deep cuts, burn injuries, and chronic ulcers. Introduction of bioactive wound care products has efficiently provided solution to treat such critical wounds and injuries. Bioactive wound dressings control infection and hasten healing process, reduce the risk of leakage, alleviate pain and discomfort. Materials such as chitosan, alginates, keratin, hydrocolloids and collagen are often the key constituents of bioactive wound dressings.

$4325 Read More
11 Aug
2016

Thyroid Gland Disorders Treatment Market By Treatments (Hypothyroidism, Hyperthyroidism) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

The thyroid gland disorders treatment market is propelling due to the factors such as rise in the patient base suffering from thyroid disorders, rising geriatric population and consistent introduction of innovative and novel therapeutics by market players leading to the growth of the market. Asia Pacific is expected to be the fastest growing market in the thyroid gland disorder treatment market due large patient base leading to large consumption of generic drugs for the treatment of thyroid diseases, especially in the countries such as China, India and Japan.

$4325 Read More
18 Aug
2016

Angiotensin Converting Enzyme (ACE) Inhibitors Market By Drug Type (Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Trandolapril, Combination ACE Inhibitors), By Applications (Hypertension, Coronary Artery Diseases, Heart Failure, Myocardial Infarction, Diabetes, Chronic Kidney Disorders) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

This report titled angiotensin converting enzyme (ACE) inhibitors market studies various drug type, application type and geographical scenario. According to Cleveland Clinic, an ACE inhibitor is a type of vasodilator that dilates the blood vessels to improve the amount of blood the heart pumps in patients suffering from high blood pressure. An ACE inhibitor also increases blood flow, which will help decrease the amount of work the heart has to do and may also decrease your blood pressure. The renin-angiotensin-aldos-terone system (RAAS) plays a key physiologic role in the regulation of blood pressure in the human body.

$4325 Read More
29 Aug
2016

Primary Biliary Cholangitis (PBC) Treatment Market Growth, Future Prospects & Competitive Analysis, 2016 - 2022

According to American Liver Foundation, primary biliary cholangitis formerly known as primary biliary cirrhosis (PBC), is a chronic liver disease that gradually destroys the medium-sized bile ducts within the liver. These bile ducts are damaged by inflammation which causes bile to remain in the liver, where gradual injury damages liver cells and causes liver cirrhosis. As cirrhosis progresses and the amount of scar tissue in the liver increases, the liver loses its ability to function

$4325 Read More
31 Aug
2016

Nonalcoholic Steatohepatitis (NASH) Treatment Market Growth, Future Prospects & Competitive Analysis, 2016 - 2023

Nonalcoholic steatohepatitis (NASH) is also known as ‘fatty liver’ a disorder that develops in patients who are not alcoholic; mainly causes liver damage that is diagnostically indistinguishable from alcoholic hepatitis. The key risk factors observed in patients suffering from NASH are obesity, glucose intolerance, and dyslipidemia. The challenges that are faced in the diagnosis of the disease are mainly due to poor understanding of pathogenesis linked to insulin resistance especially in obesity or metabolic syndrome.

$4325 Read More
08 Sep
2016

Intraosseous Devices Market By Product Type (Dieckmann Modified Needle, Jamshidi Needle, FAST1 device, FASTx device, BIG device, EZ-IO device and NIO), By Technology (Manual IO Needles, Battery Powered Driver, and Impact Driven Devices) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

The report titled “Intraosseous Devices Market- Growth, Future Prospects, and Competitive Analysis, 2016 – 2023” offers strategic insights into the overall intraosseous devices market along with the market size and estimates for the duration 2013 to 2023. The said research study covers in-depth analysis of multiple market segments based on type of products, technology and different geographies. Intraosseous infusion, a technique for vascular entry, was described initially in year 1922 and was widely applied for drug administration in children and adults in the 1940s.

$4325 Read More
14 Sep
2016

Platelet Rich Plasma (PRP) Market Growth, Future Prospects & Competitive Analysis, 2016 - 2023

Platelet rich plasma (PRP) is a product that contains large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics. PRP differs from platelet-poor tissue and fibrin glue because PRP provides a unique ability to augment wound healing process and osteogenesis. PRP functions as a safe, biocompatible prompt hemostatic agent and fast-tracks epidermal, epithelial and endothelial regeneration.

$4325 Read More
19 Sep
2016

Trientine Hydrochloride Market By Application (Epoxy Curing, Wilson’s Disease) - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023

Trientine hydrochloride is a liquid base polyamine which was first characterized by a German scientist named A.W. Holfmann in the year 1860-1862. He came across trientine hydrochloride when he was studying on his research topic amine chemistry in London at the Royal College of Chemistry. The British Pharmacopoeia Commission selected trientine in the year 1978 as the British approved name for pharmaceutical grade triethylenetetramine.

$4325 Read More
20 Sep
2016

Chronic Myeloid Leukemia (CML) Treatment Market By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy and Stem Cell Transplant), - Growth, Share, Opportunities & Competitive Analysis, 2016 -2023

The report titled “Chronic Myeloid Leukemia (CML) Treatment Market- Growth, Future Prospects, and Competitive Analysis, 2016 – 2023” offers strategic insights into the overall chronic myeloid leukemia (CML) treatment market along with the market size and estimates for the duration 2013 to 2023.

$4325 Read More
20 Sep
2016

Therapeutic Monoclonal Antibodies Market Growth, Future Prospects & Competitive Analysis, 2016 - 2024

Following the approval of the first monoclonal antibody in 1986, the approval and sales were flat until the introduction of the first chimeric monoclonal antibodies. Further approvals of humanized and fully human monoclonal antibodies, the market for therapeutic monoclonal antibodies experienced a significant surge to become a multi-billion dollar market in the current decade.

$4325 Read More
21 Sep
2016

Feminine Hygiene Products Market Growth, Future Prospects & Competitive Analysis, 2016 - 2023

Increased awareness about availability of female hygiene products due to intensive marketing strategies, the female population worldwide is increasingly prompted to adopt such products. Availability of a wide product range catering several hygiene needs and extended disposable income of the female population has led to increase in the sale of these products.

$4325 Read More
21 Sep
2016

Carcinoembryonic Antigen (CEA) Market, By Application (Ovarian Cancer, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Breast Cancer, Thyroid Cancer and Other Cancers) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

The report titled “Carcinoembryonic Antigen (CEA) Market- Growth, Future Prospects, and Competitive Analysis, 2016 – 2023” offers strategic insights into the overall carcinoembryonic antigen market along with the market size and estimates for the duration 2013 to 2023. The said research study covers in-depth analysis of multiple market segments based on type of application, and different geographies.

$4325 Read More
27 Sep
2016

Aspergillosis Treatment Market Growth, Future Prospects & Competitive Analysis, 2016 - 2023

According to the Cleveland Clinic, Aspergillosis is an infection or allergic reaction caused by various kinds of molds found on plants, soil, building materials or rotting vegetables. Aspergillosis treatment market can be segmented on the basis of several types such as allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis, aspergilloma, chronic pulmonary aspergillosis, invasive aspergillosis and cutaneous (skin) aspergillosis. ABPA is observed as one of the most common aspergillosis in which inflammation in the lungs and allergy symptoms such as coughing and wheezing are observed.

$4325 Read More
19 Oct
2016

Heart Health Supplements Market Growth, Future Prospects & Competitive Analysis, 2016 - 2023

In order to prevent cardiovascular diseases, a proper balanced diet is essential such as oily fish, vegetables, fruits, and substantial and appropriate amount of fiber in the body. Consumers’ awareness related to maintaining the heart health and demand for heart health supplements has also showcased an upliftment over the past few years in order to prevent various cardiovascular diseases.

$4325 Read More
05 Apr
2017

Trigeminal Neuralgia Treatment Market By Treatment (Drug Based, Surgery) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

This report on global trigeminal neuralgia treatment market studies various drugs used for treatment of trigeminal neuralgia along with pipeline analysis of upcoming potential drugs. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. According to the International Association for the Study of Pain the incidence of Trigeminal Neuralgia is 12 per 100,000 persons per year.

$4325 Read More
30 Nov
2016

Middle East And Africa Female Hygiene Products Market By Product (Wash/Gels, Wipes, Moisturizers), By Applications (Protection (Antiseptic & Antibacterial), Whitening, Revitalizing And Moisturizing), By Sales Channel (Departmental Stores, Supermarkets And Hypermarkets, E-Tailers) - Growth, Future Prospects & Competitive Analysis, 2016 - 2023

The report titled “MEA Female Hygiene Products Market - Growth, Share, Opportunities and Competitive Analysis, 2016–2023” offers strategic insights into the overall female hygiene products market along with the market size and estimates for the duration 2016 to 2023. The said research study covers in-depth analysis of multiple market segments based on type of products, type of applications, type of sales channel and different geographical region.

$4325 Read More
30 Nov
2016

Global Malignant Ascites Market By Key Treatment (Therapeutic, Surgical), By Application (Ovarian Cancer, Breast Cancer, Gastrointestinal Cancer, Colorectal Cancer, Carcinoma Of Unknown Primary) - Growth, Future Prospects & Competitive Analysis, 2016 - 2023

Malignant ascites indicates presence of malignant cells in the peritoneal cavity. The most common malignancies linked with development of malignant ascites are cancers of ovary, colon/rectum, breast, lung, liver, lungs and lymphoma. The survival rate of such patients is poor; however appropriate treatment modality can improve the quality of life. Traditional therapies for malignant ascites include paracentesis, shunting, drugs such as spironolactone, catumaxomab, and chemotherapy.

$4325 Read More
21 Sep
2017

Multiple Myeloma Treatment Market, By Type (Drug Therapy, Stem Cell Transplantation, Biophosphonates, Radiation Therapy, & Surgical Therapy) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

The report titled “Multiple Myeloma Treatment Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall multiple myeloma treatment market along with the market size and estimates for the duration 2015 to 2025.

$4325 Read More
09 Dec
2016

Nootropics Market By Applications (Memory Enhancement, Mood And Depression, Attention A nd Focus, Longevity And Anti-Aging, Sleep, Recovery And Dream Enhancement, Anxiety) - Growth, Future Prospects & Competitive Analysis, 2016 - 2023

The purpose of this research study titled ‘Nootropics Market - Growth, Future Prospects, and Competitive Analysis, 2016 – 2024’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global nootropics products market. This report presents and analyzes the major trends prevalent in the global nootropics market and the market size and forecast.

$4325 Read More
14 Dec
2016

Global Inulin Market By Applications (Food And Beverages, Dietary Supplements, Pharmaceuticals) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

Inulin is a term used to describe a group of polysaccharides that is produced by numerous plants. It is a type of dietary fiber which is usually found in the roots of plants. Herb chicory is a plant from which most of the inulin is extracted. As a natural fiber, inulin provides a number of important health benefits, such as helps in preventing constipation, lowers cholesterol levels, and promotes good bacteria (probiotics) in the intestinal tract.

$4325 Read More
22 Dec
2016

Global Antioxidant Market By Product (Natural Antioxidants, Synthetic Antioxidants), By Application (Pharmaceutical, Food And Beverage, Feed Additive, Cosmetic) - Growth, Future Prospects And Competitive Analysis, 2016 - 2023

Antioxidants is chemical which neutralize the free radical thus inhibiting the oxidation of the other molecule, further delaying or preventing the damage to the cells. It can be artificial or natural antioxidant such as vitamin A, vitamin C, Vitamin E, BHT, BHA etc

$4325 Read More
28 Dec
2016

Global Anti-Hypertensive Drugs Market By Type (Diuretics, ACE inhibitors, ARBs, Calcium Channel Blockers, Beta - Adrenergic blocker, Alpha - Adrenergic blocker, Central Sympatholyics, Renin inhibitors, Vasodilators): Market Growth, Future Prospects And Competitive Analysis, 2016 - 2023

Hypertension is most commonly observed chronic disease, which causes elevation in systolic and diastolic blood pressure, which in long term is high risk factor for coronary artery disease, heart failure, stroke etc.. The anti-hypertensive drugs are used to control the blood pressure. The antihypertensive drugs market major drivers is the prevalence of the chronic disease along with growing population and altering lifestyle, with increase in awareness of treatment, new drug approval and healthcare expenditure.

$4325 Read More
29 Dec
2016

Cancer Supportive Care Market By Cancer (Lung Cancer, Liver Cancer, Breast Cancer, Leukemia, Prostate Cancer, Ovarian Cancer, Bladder Cancer), By Sales Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), By Therapeutic Area (Oral Mucositis And Dry Mouth, Chemotherapy Induced Nausea And Vomiting Cancer Pain, Chemotherapy Induced Anemia, Chemotherapy Induced Neutropenia, Bone Metastases) - Growth, Future Prospects And Competitive Analysis, 2016 - 2024

Supportive care is a high importance area in cancer care and management. Prevention of radiotherapy and chemotherapy induced anemia, management or mucosal injury, treatment of dyspnea, management of cancer pain, venous thromboembolism, bone metastases, cardiovascular toxicity and others hold a critical significance and specific guidelines have been established for delivering best cancer treatment outcomes.

$4325 Read More
13 Oct
2017

Global Bacterial Conjunctivitis Market By Drug Class (Fluoroquinolones, Aminoglycosides, Macrolides and Others) - Growth, Future Prospects & Competitive Analysis, 2017- 2025

The drivers responsible for the deep market penetration of drugs utilized for treatment of bacterial conjunctivitis are the rising prevalence of bacterial conjunctivitis, water and air pollution and lack of personal hygiene. Technological advancement in the drug development with effective drug concentration such as ISV-405 (Azithromycin 2.0%) which has resulted into immediate relief as the dose required is minimum and hence less drug related adverse events.

$4325 Read More
12 Jan
2017

Parkinson’s Disease Therapeutics: Market Growth, Future Prospects & Competitive Analysis, 2016-2024

Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder of the central nervous system characterized by tremor, rigidity, postural instability, and hypokinesia. A patient’s brain slowly stops producing a neurotransmitter called dopamine, it sends messages to the part of the brain that controls movement. PD is not fatal disease but complications from this disease are more serious.

$4325 Read More
13 Jan
2017

Global Fabry Disease Therapeutic Market - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

Fabry disease is a rare, X-linked inherited, disorder of lipid metabolism resulting from the deficient activity of the enzyme, alpha-galactosidase-A. This enzyme normally responsible for the breakdown of globotriaosylceramide, results in abnormal deposits of a particular fatty substance in walls of the blood vessel throughout the body. Characteristic features of Fabry disease include episodes of pain, cloudiness of the front part of the eye, clusters of small and dark red spots on the skin, hearing loss also involves life-threatening complications such as heart attack, kidney damage and stroke.

$4325 Read More
17 Jan
2017

Global Rheumatoid Arthritis Therapeutics Market - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

Rheumatoid arthritis is an autoimmune, inflammatory disease that causes chronic pain, swelling and loss in the functioning ability of joints. It occurs when the immune system attacks the synovium – the inner lining of membranes that surrounds the joints. In some patients, the antibodies also damage some body systems including the skin, heart, eyes, lungs and blood vessels. Prevalence of rheumatoid arthritis widely varies in different geographic region, the lowest rates is observed in the Asian countries and higher rates among some American populations.

$4325 Read More
19 Jan
2017

Small Animal Respiratory Diseases Treatment Market By Type Of Diseases (Allergic Pneumonitis, Canine Influenza, Canine Nasal Mites, Lung Nematodes, Neoplasia Of Respiratory System, Pneumonia, Rhinitis And Sinusitis, Tonsilitis), By Type Of Drug Class (Anthelmintics, Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Antibiotics, Antihistamines, Phosphodiesterase (PDE) inhibitors, Bronchodilators, Antineoplastic Agents) - Growth, Future Prospects & Competitive Analysis, 2016 - 2024

This report on global small animal respiratory diseases treatment market studies various type of diseases, drug class and geography. According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.

$4325 Read More
19 May
2017

Gastrointestinal Agents Market By Drug Class (Antidiarrheal, Anti-Ulcers, Laxatives, Inflammatory Bowel Disease Irritable Bowel Syndrome) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Gastrointestinal (GI) symptoms generally include bloating, heartburn, indigestion/dyspepsia, and constipation. According to a new study, almost 74 percent of Americans suffer with digestive symptoms like gas, diarrhea, bloating and abdominal pain. In this study scope, gastrointestinal disease or disorder includes gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

$4325 Read More
24 Feb
2017

Pharmacogenomics Market By Technology (Microarray, Sequencing, Polymerase Chain Reaction), By Application (Oncology, Cardiology, Pain Management, Neurological Disorders) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

Pharmacogenomics refers to the study of the human genetic make-up and corresponding tailoring of the drug treatment. Each individual response to the drug varies according to the genetic composition. To address such variations, it is necessary to study how the drug processing is affected by the genes. Precise genetic testing helps in determining targeted drug therapies and streamline the treatment protocol to improve therapeutic results.

$4325 Read More
24 Feb
2017

Nosocomial Infection Treatment Market By Infection (Ventilator Associated Pneumonia, Urinary Tract Infection, Blood Stream Infection, Surgical Site Infection, Gastrointestinal Infection, MRSA), By Treatment (Antibacterial Treatment, Antiviral Treatment, Antifungal Treatment) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

According to the WHO, nosocomial infection is defined as “an infection acquired in hospital by a patient who was admitted for a reason other than that infection”. An infection occurring in a patient in a hospital or other health care facility in whom the infection was not present or incubating at the time of admission. This includes infections acquired in the hospital but appearing after discharge, and also occupational infections among staff of the facility.

$4325 Read More
27 Feb
2017

Treatment Resistant Depression Market By Drug Class (Tricyclic Antidepressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine Oxidase Inhibitors (MAOIs), Serotonin Neurotransmitter (5-HT2)-receptor Antagonists, Novel Agents) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

Prevalence of treatment resistant depression (TRD) appears to be substantial in the studied European nations and peaked in the 40-60 age group. Females had substantially higher disease burden, amounting to as much as twice as their male counterparts in certain age groups. According to treatment providers, patients with TRD have been found to be twice as likely as those with MDD to be hospitalized, with health care costs for hospitalized TRD patients being 5 to 6-fold higher than for non-TRD patients.

$4325 Read More
27 Feb
2017

Hospital Infection Prevention And Control Market By Infection (Pneumonia, Urinary Tract Infection, Blood Stream Infection, Surgical Site Infection, MRSA), By Product (Infection Prevention Supplies, Infection Prevention Equipment, Infection Prevention Services) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

Hospital acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries. In particular in developing countries it poses an enormous negative impact on health delivery costs. The cost may direct (the cost of medicines, bed occupation etc.) or indirect (as patients are deprived of work). According to a WHO study: 55 hospitals of 14 countries in South-East Asia, Europe, the Eastern Mediterranean and Western Pacific revealed that on average 8.7% of hospital patients suffer nosocomial infections.

$4325 Read More
28 Feb
2017

Peptide Therapeutics Market By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Phase Peptide Synthesis (HPPS)), By Delivery Route (Oral Route, Parenteral Route, Pulmonary Route, Mucosal Route), By Applications (Cancer, Cardiovascular Diseases, Metabolic Diseases, Central Nervous System, Infectious Diseases, Gastrointestinal Diseases, Renal Disorders) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

This report on global peptide therapeutics market studies various type of application, delivery route, technology and geography. The advantages of using peptide-based molecules for treatment comprises low toxicity, excellent target specificity, high potency, good tolerance, and low incidence of side-effects.

$4325 Read More
21 Mar
2017

Pre-Menstrual Syndrome Treatment Market By Drug (Analgesics (Pain Killers), Oral Contraceptive Pills (OCPs), Gonadotropin-Releasing Hormone (GnRH), Antidepressants, Ovarian Suppressors, Diuretics, Benzodiazepines) - Growth, Future Prospects And Competitive Analysis, 2016 - 2024

Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffer from PMS; and one in every twenty women demonstrate life disturbing symptoms. Pre-menstrual dysphoric disorder (PMDD) is a further severe form of PMS and demonstrates more severe symptoms of PMS, often interfering with social activities, work and emotional balance. PMDD occurs in 3% to 5% of menstruating women.

$4325 Read More
23 Mar
2017

Global Pompe Disease Therapeutics Market - Growth, Future Prospects & Competitive Analysis, 2016-2024

Pompe disease also known as lysosomal storage disorder, is an inherited, rare disease that is characterized by progressive muscle weakness and respiratory disorder. Pompe disease usually occurs in 1 in 40,000 newborn babies, where the lowest rate is observed in the countries like Australia and New Zealand and higher rate among African American populations.

$4325 Read More
23 Mar
2017

Global Gaucher Disease Therapeutics Market - Growth, Future Prospects & Competitive Analysis, 2016-2024

Gaucher disease, also known as lysosomal storage disorder is an inherited, rare disease that occurs due to less glucocerebrosidase (GCase) an enzyme which breaks down glucocerebroside building up around bone marrow, liver and spleen. Gaucher disease usually occurs in 1 in 40,000 to 60,000 newborn babies, where the lowest rate is observed in the Asia Pacific and higher rates among Eastern European populations.

$4325 Read More
29 Mar
2017

Global Asthma Therapeutics Market By Drug (Anti-Inflammatory Drugs, Bronchodilators, Combination Therapy), By Product (Dry Powder Inhalers, Metered Dose Inhalers, Mist Inhalers, Nebulizer), By Route (Inhalation, Oral, Parenteral) - Growth, Future Prospects And Competitive Analysis, 2016 - 2024

Asthma is the chronic respiratory disease which mainly affects the airways of the lung, characterized by wheezing, coughing, breathlessness, and chest tightness. Asthma can be caused by genetic or environmental factors. There is no cure for asthma but it can be controlled by using different medications. Unknown etiology of the disease is a major challenge to the asthma therapeutic market.

$4325 Read More
30 Mar
2017

Global Antibody Drug Conjugate Market By Drug (Kadcyla, Adcetris, Pipeline Analysis Of Antibody Drug Conjugate) - Growth, Future Prospects And Competitive Analysis, 2016 - 2024

Antibody Drug Conjugates are monoclonal antibodies that are attached to biologically active drugs by chemical linkers with labile bonds. By attaching biologically active chemotherapeutic drugs, radioactive isotopes, cytokines or cytotoxins via chemical linkers with liable bonds to a monoclonal antibody directed to antigens differentially overexpressed in tumor cells, ADCs significantly improve sensitive discrimination between healthy and diseased tissue.

$4325 Read More
17 Apr
2017

Prostate Cancer Treatment Market By Treatment (Biological Therapy, Chemotherapy ) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

This report on global prostate cancer treatment market studies various drugs used for treatment of prostate cancer along with pipeline analysis of upcoming potential drugs. According to National Cancer Institute approximately 12.9% of the men will be diagnosed with prostate cancer at some point during their lifetime.

$4325 Read More
03 Oct
2017

Neurological Diseases Treatment Market By Drug Type (Anticholinergic, Antiepileptic, Antipsychotic, Hypnotic & Sedative, Analgesics, Antihypertensive, Anticoagulants), By Disease (Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Cerebrovascular Disease) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

The report titled “Neurological Diseases Treatment Market- Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the overall neurological diseases treatment market along with the market size and estimates for the duration 2015 to 2025. The said research study cover in-depth analysis of neurological treatment market segments based on type of drugs, diseases and different geographies further segmented by countries.

$4325 Read More
27 Apr
2017

Biosimilars Treatment Market By Product (Recombinant Non – Glycosylated Proteins, Recombinant Glycosylated Proteins, Recombinant Peptides), By Application (Oncology, Chronic And Autoimmune Disease, Blood Disorders, Growth Hormone Disease, Infectious Disease) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

This report on global biosimilars market studies the increasing demand for biosimilars as the number of biologics drugs used for chronic diseases are set to expire in the next 3-5 years, growing pressure to curtail healthcare expenditure, cost effectiveness of biosimilars and strategic collaborations resulting into enhanced productivity and clinical trials activities for biosimilars.

$4325 Read More
02 May
2017

Glaucoma Therapeutics Market By Drug Class (Prostaglandins Analogs, Beta Blockers, Alpha-Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Fixed-Dose Combinations) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics globally.

$4325 Read More
02 May
2017

Hepatitis B Vaccine Market By Composition (Combination Vaccines, Mono Vaccines), By End Users Age (Adult Hepatitis B Vaccines, Paediatric Hepatitis B Vaccines) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Factors such as increase in awareness of hepatitis B infection prevention, governments have mandated the immunization and hepatitis B vaccine included in national immunization schedule in many countries driving the market growth of hepatitis B vaccine globally.

$4325 Read More
08 May
2017

Cryptococcosis Market By Treatment (Amphotericin B, Flucytosine, Fluconazole) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Cryptococcosis is a potentially fatal fungal disease occurs due to Cryptococcus. Factors such, increase in prevalence of fatal fungal disease, rising treatment awareness and last-stage HIV patients developing the disease are driving the growth of Cryptococcosis market worldwide.

$4325 Read More
08 May
2017

Chronic Kidney Disease (CKD) Drugs Market By Drug Class (Antihypertensive, Antihyperlipidemic, Anemia Treatment Drugs, Swelling Treatment Drugs) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Chronic kidney disease is also known as chronic renal disease or chronic kidney failure it is characterized by progressive loss in kidney function over period of time. Factors such as rising in geriatric population, increase in prevalence of CKD and favorable reimbursement policies in some countries are driving the market growth of CKD drugs worldwide.

$4325 Read More
09 May
2017

Facial Injectables Market By Product (Botulinum Toxin, Hyaluronic Acid, Collagen, Polymers And Particles) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Facial injectables or fillers are used in aesthetic medical procedures to enhance the facial look. Facial injectables are used with an intent to smoothen the wrinkles or scars on the face by filling or puffing up the target area. Continuous introduction of new products and high level promotional activities through portals, magazines and other media are aggressively barraging information about such products.

$4325 Read More
10 May
2017

Bovine Respiratory Disease Treatment Market By Treatment (Vaccines, Antibiotics, Immunomodulators), By Disease, By Distribution Cannel - Growth, Future Prospects And Competitive Analysis 2017 – 2025

The purpose of this research study titled ‘Bovine Respiratory Disease Treatment Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global bovine respiratory disease treatment market. This report presents and analyzes the major trends prevalent in the global bovine respiratory disease treatment market and the market size and forecast.

$4325 Read More
25 Jul
2017

Psoriasis Treatment Market By Drug Class (TNF Inhibitors, Vitamin D Analogues, Interleukin Blockers, Topical Corticosteroids), By Type (Plaque Psoriasis, Guttate Psoriasis, Flexural Or Inverse Psoriasis, Psoriatic Arthritis) - Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025

Psoriasis is a chronic, inflammatory, painful skin disease; currently there is no cure primary goal of treatment is to reduce inflammation and abnormal skin plaque formation. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence, significant unmet needs, promising pipeline molecules would fuel the growth of psoriasis treatment market worldwide.

$4325 Read More
15 May
2017

Pharmacy Repackaging Systems Market By Product Type (Liquid Medication Packaging Systems, Solid Medication Packaging Systems), By Dosage Type (Unit Dose Packaging, Multiple Unit Packaging) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Pharmaceutical repackaging is the act of transferring specified doses of a medication from a manufacturer's primary container into another primary container. Factors such as increase in awareness of automated systems in developed economies, significant cost saving achieve in hospital pharmacy and increase in patient compliance for unit dose packaging are driving the market growth of pharmacy repackaging systems market globally.

$4325 Read More
19 May
2017

Peripheral Neuropathy Market By Treatment (Pharmacological Therapies, Non-Pharmacological Therapies) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

General population studies have reported that 7 to 8% adults currently have chronic neuropathic pain, where the reported incidence is of 8 cases per 1,000 individuals per year. In the U.K. alone, 26% individuals with diabetes experience peripheral neuropathic pain. Globally, this figure translates to approximately 50 million individuals, which will further increase as is anticipated that the prevalence of diabetes will grow to an estimated 4.4% by 2030. Anticonvulsant pregabalin (Lyrica, Pfizer) is among the most widely spread drug for neuropathic pain.

$4325 Read More
01 Jun
2017

Asthma And COPD Drugs Market By Drug Type (Anti-Inflammatory Drugs, Bronchodilator Monotherapy, Combination Drugs, Pipeline Analysis) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Asthma is chronic respiratory disease that causes inflammation of narrowing of airways. COPD (Chronic Obstructive Pulmonary Disease) is a lung disease that makes breathing difficult including chronic bronchitis and emphysema and that gets worse with time. COPD is one of the leading cause of mortality and morbidity worldwide, with prevalence rate of 5-13%. Prevalence rate is directly proportional to increase in smoking rates and air population, especially in developing countries.

$4325 Read More
14 Jun
2017

Substance Abuse Treatment Market By Treatment (Alcohol Addiction Treatment, Nicotine Addiction Treatment, Drug Abuse Treatment) - Growth, Future Prospects, And Competitive Analysis, 2015 -2025

Substance abuse is a compulsive, excessive, and self-damaging use of habit forming drugs or substances. Factors such as rising patient awareness, higher treatment seeking rate, increased government intervention, higher number of addicted population and encouragement to curb substance abuse in all countries are driving the growth of substance abuse treatment market globally.

$4325 Read More
29 Jun
2017

Cholera Vaccines Market By Product Type (Dukoral, Shanchol, Vaxchora, Other Vaccines) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Global cholera vaccines market is anticipated to grow significantly during forecast period due to rising government initiatives in immunization program and growing incidence of cholera particularly in developing countries in Asia and Africa would drive the growth of cholera vaccines market globally.

$4325 Read More
30 Jun
2017

Animal Healthcare Market By Product Type (Additive Feed, Pharmaceuticals, Vaccines), By Animal Type (Production Animals, Companion Animals) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

This report on global animal healthcare market studies the market in terms of various product types and their applicability on different animal species. Animal healthcare has been an area of interest for many pharmaceutical companies in the last few years due to the rise in global population and increasing demand for protein rich diet. It has become even more important because of greater instances of animal disease outbreaks coupled with large scale factory farming that requires high quality animal feed additives, vaccines as well as hygiene management products.

$4325 Read More
03 Jul
2017

Influenza Therapeutics Market By Therapy Type (Vaccines, Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2025

Global influenza therapeutics market is anticipated to grow significantly during forecast period due to growing prevalence of influenza, increasing demand for treatment medication, government initiatives in awareness and treatment would drive the growth of influenza therapeutics market globally.

$4325 Read More
04 Jul
2017

Prenatal Vitamin Supplements Market By Product Type (Folic Acid, Iron Supplements, Calcium Supplements, Essential Fatty Acids), By Sales Channel (Supermarkets/Hypermarkets, Drug Stores) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Prenatal vitamin supplements consist of a variety of vitamins and minerals that are essential for the healthy development of the unborn baby. Vitamins and minerals such as iron, calcium, and folic acid are vital for proper fetal growth, development, and healthy adult living.

$4325 Read More
06 Jul
2017

Respiratory Tract Infection Treatment Market By Disease (Upper Respiratory Tract Infection, Lower Respiratory Tract Infection), By Drug Class (Antibiotics, Antiviral, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppresant, Nasal Decongestant) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

This report on global respiratory tract infection treatment market studies various diseases and drug class. Rising prevalence of respiratory illness as per World Health Organization in 2015 three million deaths were recorded due to COPD, constantly changing climate, rising air pollution and increasing inclination to maintain personal hygiene are the drivers for the respiratory tract infection treatment market.

$4325 Read More
10 Jul
2017

Erythropoietin Drugs Market By Drug Type (Epoetin-Alfa, Epoetin-Beta, Darbepoetin-Alfa), By Application Type (Anemia, Kidney Disorders) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Erythropoietin is a growth regulating hormone that stimulates the production of red blood cells. Red blood cells are produced in bone marrow and help in carrying oxygen throughout the body. Erythropoietin drugs are used to treat anemia caused due to chronic kidney diseases, cancer treatment or HIV.

$4325 Read More
17 Jul
2017

Alpha Mannosidosis Market By Indication Type (Type I, Type Ii, Type Iii), By Treatment (Bone Marrow Treatment, Enzyme Replacement Treatment) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Aplha mannosidosis is a rare geneticdisorder belonging to a group of diseases known as lysosomal storage disorders. Aplha mannosidosis occurs in 1 in every 500,000 people in the general population and is characterized by a deficiency of the enzyme alpha-D-mannosidase.The symptoms, progression and severity of alpha-mannosidosis vary widely from one person to another, including between siblings who share the same mutation.

$4325 Read More
18 Jul
2017

Allergy Diagnostics And Treatment Market By Product Type (Assay Kits, Consumables, Services), By Test Type (In Vivo Tests, In Vitro Tests), By Treatment Type (Antihistamines, Autoinjectable Epinephrine, Corticosteroids, Decongestants, Immuno Modulators, Immunotherapy, Leukotriene Inhibitors, Mast Cell Stabilizers, Nasal Anticholinergics), By Allergen Type (Food Allergen, Inhaled Allergen, Drug Allergen, Other Allergen) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Allergy is the immune reaction to foreign body called allergen; it may arise due to food consumed or inhaled into lungs or in contact with skin through injectable agent or touch. Allergic diseases rank fifth among the leading chronic diseases across all age groups in U.S. Over the period of 50 years of global industrialization, there is a substantial rise in prevalence of allergic diseases.

$4325 Read More
06 Oct
2017

Post Traumatic Stress Disorder Therapeutics Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2025

Post-Traumatic Stress Disorder (PTSD) is a mental health disorder that one develops after experiencing or witnessing a life threatening event like combat, war, a natural disaster, car accident or sexual assault. 

$4325 Read More
20 Jul
2017

Chemotherapy Induced Neutropenia Market By Treatment Type (Top 3 Countries, Antibiotic Therapy, Colony Stimulating Factor Therapy, Granulocyte Transfusion, Splenectomy Procedure) - Growth, Future Prospects, And Competitive Analysis, 2015 -2025

Chemotherapy induced neutropenia is a very common side effect of cancer chemotherapy, it is treated on the basis of etiology, severity, and duration of the neutropenia. Growing prevalence of different forms of cancer and increasing research and development activities for novel therapeutics are primarily driving the growth of chemotherapy induced neutropenia market globally.

$4325 Read More
20 Jul
2017

Burn Care Market By Product Type (Advanced Burn Care Products, Biologics, Traditional Burn Care Products), By Severity Of Burn (Minor Burns, Partial-Thickness Burns, Full-Thickness Burns) - Growth, Future Prospects, And Competitive Analysis, 2015 -2025

Burns are one of the most common public health problem and the fourth most common type of trauma worldwide. Increase in incidence of burn, rising awareness regarding treatment options, availability of advance treatment, rising number of emergency centers and government initiatives to develop the strategies for improving care are prime factors driving the growth of burn care market globally.

$4325 Read More
21 Jul
2017

Non-Alcoholic Steatohepatitis Market By Drug Type (Obeticholic Acid, Aramchol, Saroglitazar, Elafibranor) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Nonalcoholic Steatohepatitis (NASH) is the progressive form of Nonalcoholic Fatty Liver Disease (NAFLD), wherein excessive fat deposition causes inflammation and damage to the liver, eventually leading to cirrhosis and increasing risk of liver failure and hepatocellular carcinoma in some cases.

$4325 Read More
24 Jul
2017

Short Bowel Syndrome Market By Drug Type (GLP-2, Glutamine, Growth Hormones, Other Drugs) - Growth, Future Prospects, And Competitive Analysis, 2015 -2025

Short bowel syndrome is a group of complex diseases that occurs due to malfunction of a portion of small and/or large intestine. The individuals with short bowel syndrome exhibit poor absorption of nutrients such as water, fats, carbohydrates, vitamins, minerals and other vital elements which leads to malnutrition, weight loss.

$4325 Read More
25 Jul
2017

Tuberculosis Treatment Market By Drug Class (First Line Treatment, Second Line Treatment) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

This report on global tuberculosis treatment market studies various drug class. According to World Health Organization (WHO) approximately 49 million lives were saved from 2000-2015 through effective diagnosis and treatment, its end TB strategy aims to eradicate the global TB epidemic with 95% reduction in TB deaths, and to cut new cases by 90% from 2015 to 2035 and to ensure that patients are not burdened with huge expenses incurred due to TB.

$4325 Read More
31 Jul
2017

Multiple Drug Resistance Bacterial Infection Treatment Market By Vector (Critical, Medium, High), By Drug Class (Cephalosporin, Beta Lactam, Beta Lactamase Inhibitors, Oxazolidinone, Cyclic Lipopeptide, Glycolipopeptides ) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

This report on global multiple drug resistance bacterial infection treatment market studies various vectors and drug class. Rising prevalence of antimicrobial drug resistance and increasing demand for rapid diagnostic testing kits will propel the multiple drug resistance bacterial infection treatment market growth. The limiting factors related to this market are the complex regulatory approvals for the antibiotics which varies according to countries.

$4325 Read More

Global Pharmaceuticals Market Analysis
 
The pharmaceuticals sector consists of firms involved in business of development, research, marketing and branding of medicines and biologics. The pharmaceuticals industry was evaluated at 1000 brillion dollars in year 2013 as per the market reports. The industry expanded at a CAGR rate of 4.2% from year 2009 to year 2013. It developed nicely in year 2010 and in year 2011 before a diminish in its growth in year 2012 and year 2013.
 
The universal pharmaceuticals industry was stimulated by an increase in healthcare expenditure and by high growth in both evolving market sectors and biologics sections. In year 2013, ailment of cancer was the biggest section contributing about 7% to the universal pharmaceuticals market. As per a reputed market research firm, it was closely followed by the pain section and diabetes section with market shares of six percent and five percent respectively.
 
The worldwide pharmaceuticals market is predicted to cross the earnings of about 400 billion US dollars by the end of year 2018 with top ten firms contributing collectively about one third of the market share. Firms in this pharmaceuticals sector are featured by their large scale expenditure on research & development activities as well as marketing operations in order to gain or acquire a large revenue share of the total market revenue.
 
Geographical Market Share

The sub continent of North America was the biggest market in year 2013 with total incomes crossing margin of 335 billion dollars. It was followed by continent of Europe with total income of 225 billion dollars as per reports provided by a reputed market research agency. Emerging nations of APAC zone and Latin America are predicted to grow fast. Rise in expenditure in these nations will be stimulated by growing occurrence of ailments, positive government policies and enhanced healthcare facilities  plus improved healthcare infrastructure in bigger cities.